Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu Injection in Patients with Sepsis: Real-World Study
ChiCTR2200062321Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2022
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of shenfu injection in sepsis and septic shock, sponsored by West China Hospital of Sichuan University. Primary endpoints: ICU-stay duration and Hospital-stay duration. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
shenfu injection
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on ChiCTR2200062321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062321.